In silico chemical screening identifies epidermal growth factor receptor as a therapeutic target of drug-tolerant CD44v9-positive gastric cancer cells

British Journal of Cancer, Published online: 14 October 2019; doi:10.1038/s41416-019-0600-9In silico chemical screening identifies epidermal growth factor receptor as a therapeutic target of drug-tolerant CD44v9-positive gastric cancer cells
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research